120156.
(a) Using data already acquired by the State Department of Public Health and existing studies and reports, the department shall aggregate data on both the following:(1) The overall vaccine coverage rates in skilled nursing facilities that serve veterans and seniors.
(2) Preparedness of skilled nursing facilities that serve veterans and seniors to respond to viral illnesses and related post-viral illnesses.
(b) The department shall submit a report to the Assembly and Senate Committees on Health that contains all of the following information in a manner that complies with Section 9795 of the Government Code:
(1) The preparedness of the state’s network of skilled nursing facilities that serve veterans and seniors to respond to viral illnesses and related post-viral illnesses.
(2) The financial impact on individuals affected by viral illnesses and the effects of post-viral illnesses, and any costs borne by the state in treating those individuals.
(3) Health data trends on demographic groups or geographic areas of the state experiencing the highest levels of viral illness.
(c) The department shall disseminate, through the most cost-effective means available, such as all facilities letters, suggested best practices for both of the following:
(1) Increasing overall coverage rates of recommended
vaccines at skilled nursing facilities that serve veterans and seniors and improving the preparedness of those facilities to prevent and treat viral illnesses.
(2) Implementing treatment protocols for the mental, physical, and behavioral effects of viral illnesses that are particularly prevalent among veterans and seniors.
(d) The department shall identify and pursue any available federal funding to incentivize and reward skilled nursing facilities for the improvement of overall coverage rates of recommended vaccines for the prevention and treatment of viral illnesses.
(e) For purposes of this section, “viral illnesses” includes, but is not limited to, influenza, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).